News Focus
News Focus
Followers 29
Posts 2153
Boards Moderated 0
Alias Born 10/28/2007

Re: Protector post# 258178

Friday, 03/11/2016 7:51:35 AM

Friday, March 11, 2016 7:51:35 AM

Post# of 347009
"He would have cared if Bavituximab didn't work, probably the reason why PPHM shared that Bavituximab performed according SUNRISE trial design expectations. "

CP, tell me how we can say this, because if the control arm worked as well as the treatment arm, how can we say that it was the Bavi that was working in the treatment arm. It seems to me that the reason the trial failed is because we CAN'T say with any certainty that the Bavi performed as expected. Where am I going wrong?

RCJ
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y